Hongkai Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hongkai Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Honggang Liu
Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Beijing, China
2 shared publications - Quan Zhou
Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
2 shared publications - Hong Chang
Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Tieyilu No. 10, Haidian District, Beijing, China
1 shared publication Jing Luo
Department of Pathology, Beijing Fu Xing Hospital, the Capital Medical University, Beijing, China
1 shared publicationMelinda Lerwill
1 shared publicationWei Dong Chen
Beijing Fuxing Hospital affiliated to the Capital University of Medical Sciences
1 shared publication
Latest Publications
- 13 October 2012
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 77 (1) , 150-152
Adenoid cystic carcinoma of the external auditory canal associated with cholesteatoma in an 8-year-old girl
- 13 October 2012
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 77 (1) , 150-152
Adenoid cystic carcinoma of the external auditory canal associated with cholesteatoma in an 8-year-old girl
- Open Access
- 10 September 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 119
Increased numbers of P63-positive/CD117-positive cells in advanced adenoid cystic carcinoma give a poorer prognosis
Objectives: This study consisted of two parts. One part was to analyze the survival rates of adenoid cystic carcinoma (ACC) in Chinese and explain the difference between our data and the literature. The other was to analyze the relationship between the expression of CD117 and the histological grade and the prognosis. Methods: A retrospective study of 80 ACC patients was performed. Clinical data were collected, and p63, CD117 were detected by immunohistochemical staining. Results: Eighty patients received follow-ups 3 to 216 months after initial diagnosis. ACC occurred in the lacrimal gland (26.3%, n = 21), nasal cavity and parasinus (33.8%, n = 27) and other sites (40.0%, n = 33). The 5-year and 10-year survival rates were 66.41% and 10.16%, respectively. Over expression of CD117 was detected in p63-negative cells in 94.3% of cases and in p63-positive cells in 45.8%. The expression of CD117 in p63-positive cells was significantly associated with the histological grade (P<0.001) and prognosis (P = 0.037) in patients in the advanced stage. Conclusions: ACC had a good 5-year survival but poor 10-year survival in Chinese, which differed from the occidental data. More p63+/CD117+ cells were associated with a higher histological grade and poorer outcome. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1701457278762097
- 10 September 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 119
Open AccessIncreased numbers of P63-positive/CD117-positive cells in advanced adenoid cystic carcinoma give a poorer prognosis
Objectives: This study consisted of two parts. One part was to analyze the survival rates of adenoid cystic carcinoma (ACC) in Chinese and explain the difference between our data and the literature. The other was to analyze the relationship between the expression of CD117 and the histological grade and the prognosis. Methods: A retrospective study of 80 ACC patients was performed. Clinical data were collected, and p63, CD117 were detected by immunohistochemical staining. Results: Eighty patients received follow-ups 3 to 216 months after initial diagnosis. ACC occurred in the lacrimal gland (26.3%, n = 21), nasal cavity and parasinus (33.8%, n = 27) and other sites (40.0%, n = 33). The 5-year and 10-year survival rates were 66.41% and 10.16%, respectively. Over expression of CD117 was detected in p63-negative cells in 94.3% of cases and in p63-positive cells in 45.8%. The expression of CD117 in p63-positive cells was significantly associated with the histological grade (P<0.001) and prognosis (P = 0.037) in patients in the advanced stage. Conclusions: ACC had a good 5-year survival but poor 10-year survival in Chinese, which differed from the occidental data. More p63+/CD117+ cells were associated with a higher histological grade and poorer outcome. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1701457278762097
- 4 September 2012
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- Vol. 31 (5) , 273-277
Kaposiform Hemangioendothelioma in the Uterine Cervix of a 5-Year Girl
The occurrence of the vascular tumors in the female genital tract, particularly in the uterine cervix, is extremely rare. This kind of tumor has mainly been reported as either cavernous hemangiomas or capillary hemangiomas. To date, no Kaposiform hemangioendothelioma has been reported in this site. Here we presented a case of Kaposiform hemangioendothelioma without Kasabach-Merritt syndrome in the cervix of a 5-year-old girl.
- 4 September 2012
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- Vol. 31 (5) , 273-277
Kaposiform Hemangioendothelioma in the Uterine Cervix of a 5-Year Girl
The occurrence of the vascular tumors in the female genital tract, particularly in the uterine cervix, is extremely rare. This kind of tumor has mainly been reported as either cavernous hemangiomas or capillary hemangiomas. To date, no Kaposiform hemangioendothelioma has been reported in this site. Here we presented a case of Kaposiform hemangioendothelioma without Kasabach-Merritt syndrome in the cervix of a 5-year-old girl.
- 4 May 2012
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 286 (3) , 707-710
Atypical polypoid adenomyomas progressed to endometrial endometrioid adenocarcinomas
- 4 May 2012
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 286 (3) , 707-710
Atypical polypoid adenomyomas progressed to endometrial endometrioid adenocarcinomas
- 2 October 2010
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 284 (3) , 695-698
Co-existence of three rare gynecological tumors in a 79-year-old woman
The occurrence of two primary tumors simultaneously is relatively common. However, the occurrence of three kinds of gynecological tumors simultaneously is extremely rare. Here we presented a 79-year-old woman who had simultaneously three primary gynecological tumors which were relatively uncommon. Those tumors were myxoid leiomyosarcoma and endometrial mucinous adenocarcinoma in the uterus and a Leydig cell tumor in the right ovary. Uterine myxoid leiomyosarcoma is a very rare and aggressive variant of uterine sarcoma despite of its minimal even no atypia and a little mitotic activity. Mucinous endometrial adenocarcinoma is also a rare subtype which comprise only 0.6-5% of uterine cancers. Leydig cell tumor is a very rare ovarian tumor which is composed entirely or predominantly of Leydig cell.
- 2 October 2010
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 284 (3) , 695-698
Co-existence of three rare gynecological tumors in a 79-year-old woman
The occurrence of two primary tumors simultaneously is relatively common. However, the occurrence of three kinds of gynecological tumors simultaneously is extremely rare. Here we presented a 79-year-old woman who had simultaneously three primary gynecological tumors which were relatively uncommon. Those tumors were myxoid leiomyosarcoma and endometrial mucinous adenocarcinoma in the uterus and a Leydig cell tumor in the right ovary. Uterine myxoid leiomyosarcoma is a very rare and aggressive variant of uterine sarcoma despite of its minimal even no atypia and a little mitotic activity. Mucinous endometrial adenocarcinoma is also a rare subtype which comprise only 0.6-5% of uterine cancers. Leydig cell tumor is a very rare ovarian tumor which is composed entirely or predominantly of Leydig cell.